The Effect and Mechanism of Magnesium Valproate on Methamphetamine‐Addicted Rats
Addiction Biology · 2025
DOI: 10.1111/adb.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, 2025. Verfasst von Yuanrong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changs…. Hauptthemen laut MEDLINE: Valproic Acid, Methamphetamine, Amphetamine-Related Disorders, Central Nervous System Stimulants. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Valproate may hold promise as a treatment for addiction. However, there are limited studies examining the effects of magnesium valproate (VPA‐Mg) on methamphetamine (MA) addiction, and the relevant mechanisms have not been thoroughly discussed. This study aims to explore the potential therapeutic effects of VPA‐Mg on MA addiction and to investigate its possible mechanisms. The effects of VPA‐Mg on MA addiction were investigated using conditioned place preference (CPP) and behavioural sensitisation models in rats. VPA‐Mg was administered during CPP formation and extinction phases to evaluate its effects on MA‐induced CPP formation and reinstatement. Behavioural sensitisation assessed the impact of VPA‐Mg during sensitisation induction and expression phases, with spontaneous activity and MA dosing optimised beforehand. Furthermore, western blotting was performed on brain regions including the prefrontal cortex (PFC), hippocampus (Hip), nucleus accumbens (NAc) and ventral tegmental area (VTA) to measure glycogen synthase kinase 3 beta (GSK‐3β) and dopamine transporter (DAT) protein levels. VPA‐Mg did not exhibit a significant impact on MA‐induced CPP formation. VPA‐Mg significantly reduced the establishment and expression of MA‐induced behavioural sensitisation ( p < 0.01). Pre‐treatment with VPA‐Mg for 3 days before the expression period also inhibited sensitisation ( p < 0.05). In addition, the ratio of p‐GSK‐3β to t‐GSK‐3β in the PFC, Hip and VTA of rats with behavioural sensitisation significantly decreased, and the expression of DAT decreased significantly ( p < 0.01). VPA‐Mg can reverse the increase in GSK‐3β activity in the Hip and the decrease in DAT in the PFC and Hip caused by repeated MA use ( p < 0.05). VPA‐Mg exhibits anti‐addictive effects on MA dependence and relapse prevention. GSK‐3β activation and DAT downregulation in addiction‐related brain regions (PFC, Hip, VTA) are closely linked to MA addiction, suggesting potential therapeutic targets. VPA‐Mg may exert its effects by modulating these pathways, particularly in the PFC and Hip.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Psychiatry, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui, China.
- Department of Psychiatry, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
ORCID-Profile: Yuanrong Li
Zitieren
APA
Li, Y., Wang, L., Sun, Y., & Wang, X. (2025). The Effect and Mechanism of Magnesium Valproate on Methamphetamine‐Addicted Rats. Addiction Biology. https://doi.org/10.1111/adb.70084
Vancouver
Li Y, Wang L, Sun Y, Wang X. The Effect and Mechanism of Magnesium Valproate on Methamphetamine‐Addicted Rats. Addiction Biology. 2025. doi:10.1111/adb.70084
BibTeX
@article{Li2025,
author = {Li, Yuanrong and Wang, Lixin and Sun, Youhui and Wang, Xuyi},
title = {The Effect and Mechanism of Magnesium Valproate on Methamphetamine‐Addicted Rats},
journal = {Addiction Biology},
year = {2025},
doi = {10.1111/adb.70084}
}
EUVIMED